DK2510085T3 - Vokenstamcelle-afledt konditioneret medium og/eller voksenstamceller til anvendelse i den terapeutiske behandling af en tumorsygdom - Google Patents
Vokenstamcelle-afledt konditioneret medium og/eller voksenstamceller til anvendelse i den terapeutiske behandling af en tumorsygdom Download PDFInfo
- Publication number
- DK2510085T3 DK2510085T3 DK10788321.7T DK10788321T DK2510085T3 DK 2510085 T3 DK2510085 T3 DK 2510085T3 DK 10788321 T DK10788321 T DK 10788321T DK 2510085 T3 DK2510085 T3 DK 2510085T3
- Authority
- DK
- Denmark
- Prior art keywords
- adult stem
- therapeutic treatment
- conditioned medium
- tumor disease
- stem cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/14—Coculture with; Conditioned medium produced by hepatocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09425504A EP2333047A1 (en) | 2009-12-09 | 2009-12-09 | Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
PCT/EP2010/069049 WO2011070001A1 (en) | 2009-12-09 | 2010-12-07 | Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2510085T3 true DK2510085T3 (da) | 2019-10-14 |
Family
ID=42111703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10788321.7T DK2510085T3 (da) | 2009-12-09 | 2010-12-07 | Vokenstamcelle-afledt konditioneret medium og/eller voksenstamceller til anvendelse i den terapeutiske behandling af en tumorsygdom |
Country Status (9)
Country | Link |
---|---|
US (1) | US9034335B2 (da) |
EP (2) | EP2333047A1 (da) |
JP (1) | JP5788405B2 (da) |
CN (1) | CN102686723B (da) |
DK (1) | DK2510085T3 (da) |
ES (1) | ES2752348T3 (da) |
PL (1) | PL2510085T3 (da) |
PT (1) | PT2510085T (da) |
WO (1) | WO2011070001A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011252915B2 (en) | 2010-05-12 | 2016-05-19 | Prokidney | Bioactive renal cells |
BR112013013869A2 (pt) * | 2010-12-06 | 2016-12-06 | Thd Spa | método para diagnóstico de um carcinoma e usos do mesmo |
US10047345B2 (en) | 2012-02-13 | 2018-08-14 | Gamida-Cell Ltd. | Culturing of mesenchymal stem cells with FGF4 and nicotinamide |
CN103387959A (zh) * | 2012-10-19 | 2013-11-13 | 夏佑红 | 一种乳牙干细胞及其制备方法和应用 |
CN104099294A (zh) * | 2013-04-03 | 2014-10-15 | 北京京蒙高科干细胞技术有限公司 | 基于干细胞分泌因子的培养基及其制备和使用方法 |
WO2014203267A2 (en) * | 2013-06-17 | 2014-12-24 | Kasiak Research Pvt. Ltd. | Method for isolation, purification and industrial scale expansion of human adipose tissue derived mesenchymal stem cells |
WO2015001124A1 (en) | 2013-07-05 | 2015-01-08 | Université Catholique de Louvain | Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders |
KR102297734B1 (ko) * | 2014-01-24 | 2021-09-03 | 가부시키가이샤 쿠오리맨 앤 코. | 암 치료용 의약 조성물 및 그 조성물을 유효 성분으로 하는 암 치료용 의약 제제 |
RU2644650C2 (ru) | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
WO2017123312A2 (en) * | 2015-09-02 | 2017-07-20 | Regeneration Worldwide Company, Inc. | Composition and methods of using umbilical cord lining stem cells |
JP7108537B2 (ja) * | 2016-04-27 | 2022-07-28 | ロート製薬株式会社 | Cd201、cd46、cd56、cd147及びcd165からなる群より選択される少なくとも1種の細胞表面マーカーを発現する間葉系幹細胞及びその調製方法、並びに上記間葉系幹細胞を含む医薬組成物及びその調製方法 |
RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
CA3085662A1 (en) | 2017-12-14 | 2019-06-20 | Unicyte Ev Ag | Pharmaceutical carriers containing mirnas for use in the treatment of renal cancer |
CN111454892A (zh) * | 2020-03-12 | 2020-07-28 | 成都世联康健生物科技有限公司 | 牙间充质干细胞培养基及在牙髓干细胞内的活性验证方法 |
CN116249539A (zh) * | 2020-09-03 | 2023-06-09 | 学校法人自治医科大学 | 间充质干细胞或自其衍生的前体细胞的培养上清的净化浓缩物及其制造方法 |
JP2024516548A (ja) * | 2021-04-08 | 2024-04-16 | ジョスリン ダイアビーティス センター インコーポレイテッド | 腎機能低下の診断及び予測の方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005205240B2 (en) * | 2004-01-14 | 2011-04-21 | Novahep Ab | Human hepatic progenitor cells and methods of use thereof |
WO2006126219A1 (en) | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
WO2008020815A1 (en) * | 2006-08-15 | 2008-02-21 | Agency For Science, Technology And Research | Mesenchymal stem cell conditioned medium |
CN101356264B (zh) * | 2005-12-21 | 2014-05-14 | 鲁汶大学 | 分离的肝脏干细胞 |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
WO2009105044A1 (en) * | 2008-02-22 | 2009-08-27 | Agency For Science, Technology And Research (A*Star) | Mesenchymal stem cell particles |
BRPI0909866B1 (pt) * | 2008-06-11 | 2021-08-24 | Fresenius Medical Care Deutschland Gmbh | Método de produção de um meio condicionado de células progenitoras de fígado, meio condicionado e composição farmacêutica |
-
2009
- 2009-12-09 EP EP09425504A patent/EP2333047A1/en not_active Withdrawn
-
2010
- 2010-12-07 PT PT107883217T patent/PT2510085T/pt unknown
- 2010-12-07 WO PCT/EP2010/069049 patent/WO2011070001A1/en active Application Filing
- 2010-12-07 EP EP10788321.7A patent/EP2510085B1/en active Active
- 2010-12-07 ES ES10788321T patent/ES2752348T3/es active Active
- 2010-12-07 DK DK10788321.7T patent/DK2510085T3/da active
- 2010-12-07 PL PL10788321T patent/PL2510085T3/pl unknown
- 2010-12-07 JP JP2012542512A patent/JP5788405B2/ja active Active
- 2010-12-07 US US13/514,719 patent/US9034335B2/en active Active
- 2010-12-07 CN CN201080055957.6A patent/CN102686723B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013513366A (ja) | 2013-04-22 |
CN102686723B (zh) | 2016-11-23 |
EP2510085A1 (en) | 2012-10-17 |
EP2510085B1 (en) | 2019-08-07 |
PL2510085T3 (pl) | 2020-01-31 |
JP5788405B2 (ja) | 2015-09-30 |
US20120251489A1 (en) | 2012-10-04 |
CN102686723A (zh) | 2012-09-19 |
ES2752348T3 (es) | 2020-04-06 |
EP2333047A1 (en) | 2011-06-15 |
US9034335B2 (en) | 2015-05-19 |
PT2510085T (pt) | 2019-10-30 |
WO2011070001A1 (en) | 2011-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2510085T3 (da) | Vokenstamcelle-afledt konditioneret medium og/eller voksenstamceller til anvendelse i den terapeutiske behandling af en tumorsygdom | |
DK2375907T3 (da) | Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller | |
DK2793929T3 (da) | Konditioneret medium opnået fra mesenkymale stamceller fra placenta og anvendelser deraf i den terapeutiske behandling af præeklampsi | |
GB2450603B (en) | Human pluripotent stem cells and their medical use | |
BRPI1011801A2 (pt) | membranas biométricas e seus usos. | |
DK2245199T3 (da) | Anvendelse af mikrovesikler i diagnosticering, prognosticering og behandling af medicinske sygdomme og tilstande | |
BRPI0912292A2 (pt) | composições e métodos para o uso de células no tratamento do tecido cardíaco. | |
BRPI1010718A2 (pt) | sistemas modelo e regimes de tratamento para tratar doença neurológica. | |
DK2480574T3 (da) | Anti-cd33-antistoffer og deres anvendelse til immunotargeting i behandlingen af cd33-associerede sygdomme | |
DK3176254T3 (da) | Anvendelse af fedtvæv-afledte stromale stamceller i behandling af fistel | |
BR112014005355A2 (pt) | células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença | |
PL2254870T3 (pl) | Pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób opartych na ekspresji MCP-1, CX3CR1 | |
DK3016665T3 (da) | Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser | |
BR112012000370A2 (pt) | derivados de 1,2,4-tiazolidin-3-ona e seus usos no tratamento de câncer | |
BR112012001344A2 (pt) | derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças | |
BRPI1008517A2 (pt) | direcionamento duplo de mir-208 e mir-499 no tratamento de doenças cardíacas. | |
BRPI0819519A2 (pt) | Análogos de triarilmetano e seus usos no tratamento de cânceres. | |
ZA201204521B (en) | Beta-cell replication promoting compounds and methods of the their use | |
DK2262778T3 (da) | 1-benzyl-3-hydroxymethylindazolderivativer og brug deraf i behandling af sygdomme baseret på ekspression af mcp-1, cxcr1 og p40 | |
IL207278A0 (en) | 1 - benzyl - 3 - hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp - 1, and cx3cr1 | |
DK2158201T3 (da) | Derivater af 7-alkynyl-1,8-naphthyridon, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapi | |
DK2310383T3 (da) | 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
DK2293846T3 (da) | Depsipeptider og deres terapeutiske anvendelse | |
DK2859092T3 (da) | Terapeutisk vaccine til behandling af diabetes type-1 hos børn, anvendelse af cellesorter og fremgangsmåde til at multiplicere treg-celler til fremstilling af terapeutisk vaccine til behandling af diabetes type-1 | |
HRP20151393T8 (hr) | UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE |